再鼎医药(ZLAB)今日股价在盘前交易中大涨6.04%,引发市场关注。根据消息,再鼎医药计划发售784万股美国存托股份,每股发售价为25.5美元,预计将为公司带来1.88亿到2.16亿美元的融资。
较纳斯达克和香港股市上一个交易日的收盘价,再鼎医药此次发行有一定折价,折让约4.39%和10.64%。公司表示,发行所得款项将用于一般企业用途,增强资金流动性并支持业务发展。
市场分析认为,这一大规模的融资计划显示再鼎医药正在积极扩大融资渠道,为公司注入新的资金助力未来增长。投资者对此反应积极,预计公司未来在业务拓展和研发等方面将有所突破,因此在盘前阶段集中买盘,推动股价上涨。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.